|
Simonelli-Muñoz AJ, Balanza S, Rivera-Caravaca JM, Vera-Catalán T, Lorente AM, Gallego-Gómez JI. Reliability and validity of the student stress inventory-stress manifestations questionnaire and its association with personal and academic factors in university students. Nurse Educ Today. 2018 May;64:156-160. doi: 10.1016/j.nedt.2018.02.019. Epub 2018 Feb 22. PubMed PMID: 29494939.
AÑO: 2018; IF: 2.442
|
29494939
|
Esteve-Pastor MA, Ruíz-Nodar JM, Orenes-Piñero E, Rivera-Caravaca JM, Quintana-Giner M, Véliz-Martínez A, Tello-Montoliu A, PerniasEscrig V, Sandín Rollán M, Vicente-Ibarra N, MacíasVillanego MJ, Candela Sánchez E, Carrillo Alemán L, Lozano T, Valdés M, Marín F. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):57-65. doi: 10.1177/1074248417724869. Epub 2017 Aug 9. PubMed PMID: 28789568.
AÑO: 2018; IF: 2.57
|
|
Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Romiti GF, Marin F, Lip GYH. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores. J Am Heart Assoc. 2018 Sep 18;7(18):e009766. doi: 10.1161/JAHA.118.009766. PubMed PMID: 30371183; PubMed Central PMCID: PMC6222935.
AÑO: 2018; IF: 4.66
|
|
Rivera-Caravaca JM, Esteve-Pastor MA, Marín F, Valdés M, Vicente V, Roldán V, Lip GYH. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. Mayo Clin Proc. 2018 Aug;93(8):1065-1073. doi: 10.1016/j.mayocp.2018.01.028. Epub 2018 May 2. PubMed PMID: 29730090.
AÑO: 2018; IF: 11.104
|
|
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PubMed PMID: 29577257.
AÑO: 2018; IF: 5.722
|